137 related articles for article (PubMed ID: 19608901)
21. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation.
Kuyumcu-Martinez NM; Wang GS; Cooper TA
Mol Cell; 2007 Oct; 28(1):68-78. PubMed ID: 17936705
[TBL] [Abstract][Full Text] [Related]
22. Absconding with the threesome.
Sachidanandan C
Trends Cell Biol; 2001 Dec; 11(12):462. PubMed ID: 11719038
[No Abstract] [Full Text] [Related]
23. Developmental insights into the pathology of and therapeutic strategies for DM1: Back to the basics.
Chau A; Kalsotra A
Dev Dyn; 2015 Mar; 244(3):377-90. PubMed ID: 25504326
[TBL] [Abstract][Full Text] [Related]
24. Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy.
Wang PY; Lin YM; Wang LH; Kuo TY; Cheng SJ; Wang GS
Hum Mol Genet; 2017 Jun; 26(12):2247-2257. PubMed ID: 28369378
[TBL] [Abstract][Full Text] [Related]
25. Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts.
Langlois MA; Lee NS; Rossi JJ; Puymirat J
Mol Ther; 2003 May; 7(5 Pt 1):670-80. PubMed ID: 12718910
[TBL] [Abstract][Full Text] [Related]
26. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.
Ranum LP; Day JW
Curr Neurol Neurosci Rep; 2002 Sep; 2(5):465-70. PubMed ID: 12169228
[TBL] [Abstract][Full Text] [Related]
27. Pathogenic mechanisms of myotonic dystrophy.
Lee JE; Cooper TA
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1281-6. PubMed ID: 19909263
[TBL] [Abstract][Full Text] [Related]
28. A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I.
Zhang F; Bodycombe NE; Haskell KM; Sun YL; Wang ET; Morris CA; Jones LH; Wood LD; Pletcher MT
Hum Mol Genet; 2017 Aug; 26(16):3056-3068. PubMed ID: 28535287
[TBL] [Abstract][Full Text] [Related]
29. Dystrophia myotonia: why focus on foci?
Junghans RP
Eur J Hum Genet; 2009 May; 17(5):543-53. PubMed ID: 19172994
[TBL] [Abstract][Full Text] [Related]
30. Reversal of fortune.
Timchenko L
Nat Genet; 2006 Sep; 38(9):976-7. PubMed ID: 16941004
[No Abstract] [Full Text] [Related]
31. Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios.
Tiscornia G; Mahadevan MS
Mol Cell; 2000 Jun; 5(6):959-67. PubMed ID: 10911990
[TBL] [Abstract][Full Text] [Related]
32. Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice.
Roberts R; Timchenko NA; Miller JW; Reddy S; Caskey CT; Swanson MS; Timchenko LT
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13221-6. PubMed ID: 9371827
[TBL] [Abstract][Full Text] [Related]
33. Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein.
Michalowski S; Miller JW; Urbinati CR; Paliouras M; Swanson MS; Griffith J
Nucleic Acids Res; 1999 Sep; 27(17):3534-42. PubMed ID: 10446244
[TBL] [Abstract][Full Text] [Related]
34. Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I.
Herrendorff R; Faleschini MT; Stiefvater A; Erne B; Wiktorowicz T; Kern F; Hamburger M; Potterat O; Kinter J; Sinnreich M
J Biol Chem; 2016 Aug; 291(33):17165-77. PubMed ID: 27298317
[TBL] [Abstract][Full Text] [Related]
35. Small-molecule-mediated cleavage of RNA in living cells.
Guan L; Disney MD
Angew Chem Int Ed Engl; 2013 Jan; 52(5):1462-5. PubMed ID: 23280953
[TBL] [Abstract][Full Text] [Related]
36. Mass spectrometry analysis of complexes formed by myotonic dystrophy protein kinase (DMPK).
Forner F; Furlan S; Salvatori S
Biochim Biophys Acta; 2010 Jun; 1804(6):1334-41. PubMed ID: 20188867
[TBL] [Abstract][Full Text] [Related]
37. Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy.
Wheeler TM; Lueck JD; Swanson MS; Dirksen RT; Thornton CA
J Clin Invest; 2007 Dec; 117(12):3952-7. PubMed ID: 18008009
[TBL] [Abstract][Full Text] [Related]
38. Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy.
Mahadevan MS; Yadava RS; Yu Q; Balijepalli S; Frenzel-McCardell CD; Bourne TD; Phillips LH
Nat Genet; 2006 Sep; 38(9):1066-70. PubMed ID: 16878132
[TBL] [Abstract][Full Text] [Related]
39. Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy.
Orengo JP; Chambon P; Metzger D; Mosier DR; Snipes GJ; Cooper TA
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2646-51. PubMed ID: 18272483
[TBL] [Abstract][Full Text] [Related]
40. HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence.
Kim DH; Langlois MA; Lee KB; Riggs AD; Puymirat J; Rossi JJ
Nucleic Acids Res; 2005; 33(12):3866-74. PubMed ID: 16027111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
